_id

69105745ccc777a4e85d5679

Ticker

CURX

Name

Curanex Pharmaceuticals Inc Common Stock

Exchange

NASDAQ

Address

2 Jericho Plaza, Jericho, NY, United States, 11753

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.curanexpharma.com

Description

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.

Last Close

0.333

Volume

236543

Current Price

0.3691

Change

-0.0044

Last Updated

2026-01-02T12:13:32.099Z

Image

data:image/webp;base64,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

Ipo Date

2025-08-26T00:00:00.000Z

Market Cap

9369472

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.989

Sentiment Sources

1

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

951327

Operating Income

-951327

Interest Expense

4090

Pretax Income

-954059

Net Income

-954059

Eps

-0.03726840573315136

Dividends Per Share

-

Shares Outstanding

28340812

Income Tax Expense

-

EBITDA

-934530

Operating Margin

-

Total Other Income Expense Net

-2732

Cash

5830537

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

14417759

Property Plant Equipment

60398

Total Assets

14478157

Payables

114489

Short Term Debt

61150

Long Term Debt

-

Total Liabilities

185955

Equity

14292202

Bs_currency_symbol

USD

Depreciation

15439

Change In Working Capital

271763

Cash From Operations

-9187019

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

14908695

Net Change In Cash

5721675

Cf_currency_symbol

USD

PE

-

PB

0.6611185109404415

ROE

-6.6753814422718065

ROA

-6.589643971950297

FCF

-9187019

Fcf Percent

-

Piotroski FScore

0

Health Score

41

Deep Value Investing Score

6

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

6.5

Quality Investing Score

2.5

Value Investing Score

5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

951327

Quarters > 0 > income Statement > operating Income

-951327

Quarters > 0 > income Statement > interest Expense

4090

Quarters > 0 > income Statement > pretax Income

-954059

Quarters > 0 > income Statement > net Income

-954059

Quarters > 0 > income Statement > eps

-0.03726840573315136

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

25599673

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-934530

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-2732

Quarters > 0 > income Statement > currency_symbol

USD

Quarters > 0 > balance Sheet > cash

5830537

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

14417759

Quarters > 0 > balance Sheet > property Plant Equipment

60398

Quarters > 0 > balance Sheet > total Assets

14478157

Quarters > 0 > balance Sheet > payables

114489

Quarters > 0 > balance Sheet > short Term Debt

61150

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

185955

Quarters > 0 > balance Sheet > equity

14292202

Quarters > 0 > balance Sheet > currency_symbol

USD

Quarters > 0 > cash Flow > net Income

-954059

Quarters > 0 > cash Flow > depreciation

15439

Quarters > 0 > cash Flow > change In Working Capital

271763

Quarters > 0 > cash Flow > cash From Operations

-9187019

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

14908695

Quarters > 0 > cash Flow > net Change In Cash

5721675

Quarters > 0 > cash Flow > currency_symbol

USD

Quarters > 0 > ratios > PE

-0.03726840573315136

Quarters > 0 > ratios > PB

0.6611185109404415

Quarters > 0 > ratios > ROE

-6.6753814422718065

Quarters > 0 > ratios > ROA

-6.589643971950297

Quarters > 0 > ratios > FCF

-9187019

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

41

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

15030

Quarters > 1 > income Statement > gross Profit

-15030

Quarters > 1 > income Statement > operating Expenses

57658

Quarters > 1 > income Statement > operating Income

-57658

Quarters > 1 > income Statement > interest Expense

3091

Quarters > 1 > income Statement > pretax Income

-60346

Quarters > 1 > income Statement > net Income

-60346

Quarters > 1 > income Statement > eps

-0.0021746306306306305

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

27750000

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-42225

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-2688

Quarters > 1 > income Statement > currency_symbol

USD

Quarters > 1 > balance Sheet > cash

108862

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

711337

Quarters > 1 > balance Sheet > property Plant Equipment

75837

Quarters > 1 > balance Sheet > total Assets

787174

Quarters > 1 > balance Sheet > payables

269

Quarters > 1 > balance Sheet > short Term Debt

70636

Quarters > 1 > balance Sheet > long Term Debt

400000

Quarters > 1 > balance Sheet > total Liabilities

481743

Quarters > 1 > balance Sheet > equity

305431

Quarters > 1 > balance Sheet > currency_symbol

USD

Quarters > 1 > cash Flow > net Income

-60346

Quarters > 1 > cash Flow > depreciation

15030

Quarters > 1 > cash Flow > change In Working Capital

-244765

Quarters > 1 > cash Flow > cash From Operations

-290081

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

200000

Quarters > 1 > cash Flow > net Change In Cash

-90081

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

-0.0021746306306306305

Quarters > 1 > ratios > PB

33.534660856298146

Quarters > 1 > ratios > ROE

-19.757653938205355

Quarters > 1 > ratios > ROA

-7.66615767289062

Quarters > 1 > ratios > FCF

-290081

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

24

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

137452

Quarters > 2 > income Statement > operating Income

-137452

Quarters > 2 > income Statement > interest Expense

1356

Quarters > 2 > income Statement > pretax Income

-137583

Quarters > 2 > income Statement > net Income

-137583

Quarters > 2 > income Statement > eps

-0.004957945945945946

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

27750000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-121594

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

-131

Quarters > 2 > income Statement > currency_symbol

USD

Quarters > 2 > balance Sheet > cash

198943

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

696072

Quarters > 2 > balance Sheet > property Plant Equipment

90868

Quarters > 2 > balance Sheet > total Assets

786940

Quarters > 2 > balance Sheet > payables

126057

Quarters > 2 > balance Sheet > short Term Debt

62618

Quarters > 2 > balance Sheet > long Term Debt

200000

Quarters > 2 > balance Sheet > total Liabilities

421163

Quarters > 2 > balance Sheet > equity

365777

Quarters > 2 > balance Sheet > currency_symbol

USD

Quarters > 2 > cash Flow > net Income

-137583

Quarters > 2 > cash Flow > depreciation

14633

Quarters > 2 > cash Flow > change In Working Capital

-26998

Quarters > 2 > cash Flow > cash From Operations

-149948

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

200000

Quarters > 2 > cash Flow > net Change In Cash

50052

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

-0.004957945945945946

Quarters > 2 > ratios > PB

28.002102373850732

Quarters > 2 > ratios > ROE

-37.61390136613292

Quarters > 2 > ratios > ROA

-17.483289704424735

Quarters > 2 > ratios > FCF

-149948

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

24

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

138591

Quarters > 3 > income Statement > operating Income

-138591

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-137163

Quarters > 3 > income Statement > net Income

-137163

Quarters > 3 > income Statement > eps

-0.004942810810810811

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

27750000

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-63915

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

1428

Quarters > 3 > income Statement > currency_symbol

USD

Quarters > 3 > balance Sheet > cash

148891

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

517935

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

517935

Quarters > 3 > balance Sheet > payables

5000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

14575

Quarters > 3 > balance Sheet > equity

503360

Quarters > 3 > balance Sheet > currency_symbol

USD

Quarters > 3 > cash Flow > net Income

-137163

Quarters > 3 > cash Flow > depreciation

0

Quarters > 3 > cash Flow > change In Working Capital

-32942

Quarters > 3 > cash Flow > cash From Operations

-95429

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

0

Quarters > 3 > cash Flow > net Change In Cash

-95429

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

-0.004942810810810811

Quarters > 3 > ratios > PB

20.348309361093452

Quarters > 3 > ratios > ROE

-27.24948347107438

Quarters > 3 > ratios > ROA

-26.48266674389643

Quarters > 3 > ratios > FCF

-95429

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

35

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

0

Annuals > 0 > income Statement > cost Of Revenue

-

Annuals > 0 > income Statement > gross Profit

-

Annuals > 0 > income Statement > operating Expenses

365062

Annuals > 0 > income Statement > operating Income

-365062

Annuals > 0 > income Statement > interest Expense

-

Annuals > 0 > income Statement > pretax Income

-361506

Annuals > 0 > income Statement > net Income

-361506

Annuals > 0 > income Statement > eps

-0.013027243243243244

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

27750000

Annuals > 0 > income Statement > income Tax Expense

-

Annuals > 0 > income Statement > EBITDA

-290386

Annuals > 0 > income Statement > operating Margin

-

Annuals > 0 > income Statement > total Other Income Expense Net

3556

Annuals > 0 > income Statement > currency_symbol

USD

Annuals > 0 > balance Sheet > cash

148891

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

-

Annuals > 0 > balance Sheet > inventories

-

Annuals > 0 > balance Sheet > total Current Assets

517935

Annuals > 0 > balance Sheet > property Plant Equipment

-

Annuals > 0 > balance Sheet > total Assets

517935

Annuals > 0 > balance Sheet > payables

5000

Annuals > 0 > balance Sheet > short Term Debt

-

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

14575

Annuals > 0 > balance Sheet > equity

503360

Annuals > 0 > balance Sheet > currency_symbol

USD

Annuals > 0 > cash Flow > net Income

-361506

Annuals > 0 > cash Flow > depreciation

0

Annuals > 0 > cash Flow > change In Working Capital

-268745

Annuals > 0 > cash Flow > cash From Operations

-555575

Annuals > 0 > cash Flow > capital Expenditures

5

Annuals > 0 > cash Flow > cash From Investing

-

Annuals > 0 > cash Flow > cash From Financing

630100

Annuals > 0 > cash Flow > net Change In Cash

74525

Annuals > 0 > cash Flow > currency_symbol

USD

Annuals > 0 > ratios > PE

-0.013027243243243244

Annuals > 0 > ratios > PB

18.225822472981562

Annuals > 0 > ratios > ROE

-71.81857914812461

Annuals > 0 > ratios > ROA

-69.79756147006864

Annuals > 0 > ratios > FCF

-555580

Annuals > 0 > ratios > Piotroski FScore

1

Annuals > 0 > ratios > fcf Percent

-

Annuals > 0 > health Score

27

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

0

Annuals > 1 > income Statement > cost Of Revenue

0

Annuals > 1 > income Statement > gross Profit

0

Annuals > 1 > income Statement > operating Expenses

19298

Annuals > 1 > income Statement > operating Income

-19298

Annuals > 1 > income Statement > interest Expense

-

Annuals > 1 > income Statement > pretax Income

-19198

Annuals > 1 > income Statement > net Income

-19198

Annuals > 1 > income Statement > eps

-0.0004570952380952381

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

42000000

Annuals > 1 > income Statement > income Tax Expense

-

Annuals > 1 > income Statement > EBITDA

-17483

Annuals > 1 > income Statement > operating Margin

-

Annuals > 1 > income Statement > total Other Income Expense Net

100

Annuals > 1 > income Statement > currency_symbol

USD

Annuals > 1 > balance Sheet > cash

74366

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

-

Annuals > 1 > balance Sheet > inventories

0

Annuals > 1 > balance Sheet > total Current Assets

74366

Annuals > 1 > balance Sheet > property Plant Equipment

-

Annuals > 1 > balance Sheet > total Assets

74366

Annuals > 1 > balance Sheet > payables

0

Annuals > 1 > balance Sheet > short Term Debt

-

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

14276

Annuals > 1 > balance Sheet > equity

60090

Annuals > 1 > balance Sheet > currency_symbol

USD

Annuals > 1 > cash Flow > net Income

-19198

Annuals > 1 > cash Flow > depreciation

1815

Annuals > 1 > cash Flow > change In Working Capital

17263

Annuals > 1 > cash Flow > cash From Operations

-120

Annuals > 1 > cash Flow > capital Expenditures

0

Annuals > 1 > cash Flow > cash From Investing

-

Annuals > 1 > cash Flow > cash From Financing

72056

Annuals > 1 > cash Flow > net Change In Cash

71936

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-0.0004570952380952381

Annuals > 1 > ratios > PB

231.0733899151273

Annuals > 1 > ratios > ROE

-31.94874355133966

Annuals > 1 > ratios > ROA

-25.81556087459323

Annuals > 1 > ratios > FCF

-120

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-

Annuals > 1 > health Score

26

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

26000

Annuals > 2 > income Statement > cost Of Revenue

21571

Annuals > 2 > income Statement > gross Profit

4429

Annuals > 2 > income Statement > operating Expenses

24662

Annuals > 2 > income Statement > operating Income

-20233

Annuals > 2 > income Statement > interest Expense

-

Annuals > 2 > income Statement > pretax Income

-20233

Annuals > 2 > income Statement > net Income

-20233

Annuals > 2 > income Statement > eps

-0.00048173809523809524

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

42000000

Annuals > 2 > income Statement > income Tax Expense

-

Annuals > 2 > income Statement > EBITDA

925

Annuals > 2 > income Statement > operating Margin

-77.81923076923077

Annuals > 2 > income Statement > total Other Income Expense Net

-

Annuals > 2 > income Statement > currency_symbol

USD

Annuals > 2 > balance Sheet > cash

2430

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

-

Annuals > 2 > balance Sheet > inventories

2987

Annuals > 2 > balance Sheet > total Current Assets

10232

Annuals > 2 > balance Sheet > property Plant Equipment

-

Annuals > 2 > balance Sheet > total Assets

10232

Annuals > 2 > balance Sheet > payables

-

Annuals > 2 > balance Sheet > short Term Debt

-

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

0

Annuals > 2 > balance Sheet > equity

10232

Annuals > 2 > balance Sheet > currency_symbol

USD

Annuals > 2 > cash Flow > net Income

-20233

Annuals > 2 > cash Flow > depreciation

21158

Annuals > 2 > cash Flow > change In Working Capital

2411

Annuals > 2 > cash Flow > cash From Operations

3336

Annuals > 2 > cash Flow > capital Expenditures

0

Annuals > 2 > cash Flow > cash From Investing

-

Annuals > 2 > cash Flow > cash From Financing

-3000

Annuals > 2 > cash Flow > net Change In Cash

336

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

-0.00048173809523809524

Annuals > 2 > ratios > PB

1357.0367474589525

Annuals > 2 > ratios > ROE

-197.74237685691946

Annuals > 2 > ratios > ROA

-197.74237685691946

Annuals > 2 > ratios > FCF

3336

Annuals > 2 > ratios > Piotroski FScore

2

Annuals > 2 > ratios > fcf Percent

0.12830769230769232

Annuals > 2 > health Score

39

Valuation > metrics > PE

-0.03726840573315136

Valuation > metrics > PB

0.6611185109404415

Valuation > final Score

70

Valuation > verdict

33.9% Undervalued

Profitability > metrics > ROE

-6.6753814422718065

Profitability > metrics > ROA

-6.617248908100073

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.013010941211158365

Risk > metrics > Interest Coverage

-232.59828850855746

Risk > final Score

-870

Risk > verdict

High

Liquidity > metrics > Current Ratio

82.08745779695853

Liquidity > metrics > Quick Ratio

82.08745779695853

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

-45

Prev Risks > 1

-375

Prev Risks > 2

52

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T21:40:42.584Z

Earnings History > 0 > period

2025-09-30

Earnings History > 0 > report Date

2025-09-30

Earnings History > 0 > date

2025-09-30

Earnings History > 0 > before After Market

-

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-0.0337

Earnings History > 0 > eps Estimate

-

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-

Earnings History > 1 > period

2025-06-30

Earnings History > 1 > report Date

2025-07-01

Earnings History > 1 > date

2025-06-30

Earnings History > 1 > before After Market

-

Earnings History > 1 > currency

-

Earnings History > 1 > eps Actual

-0.01

Earnings History > 1 > eps Estimate

0

Earnings History > 1 > eps Difference

-0.01

Earnings History > 1 > surprise Percent

-